• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Research in Oncology
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 21 (2025)
Volume Volume 20 (2024)
Volume Volume 19 (2023)
Volume Volume 18 (2022)
Volume Volume 17 (2021)
Volume Volume 16 (2020)
Volume Volume 15 (2019)
Volume Volume 14 (2018)
Issue Issue 2
Issue Issue 1
Volume Volume 13 (2017)
Volume Volume 12 (2016)
Ellithy, M., Ashoush, N., El Shahat, K., Ahmed, E., Abdelsalam, M. (2018). Intensity Modulated Radiation Therapy versus Supportive Care in Malignant Pleural Mesothelioma: A Pilot Study for Treatment Outcomes and Cost-Effective Expectations. Research in Oncology, 14(1), 6-11. doi: 10.21608/resoncol.2018.2409.1042
Mahmoud Ellithy; Nermeen Ashoush; Khalid El Shahat; Emad Ahmed; Mahmoud Abdelsalam. "Intensity Modulated Radiation Therapy versus Supportive Care in Malignant Pleural Mesothelioma: A Pilot Study for Treatment Outcomes and Cost-Effective Expectations". Research in Oncology, 14, 1, 2018, 6-11. doi: 10.21608/resoncol.2018.2409.1042
Ellithy, M., Ashoush, N., El Shahat, K., Ahmed, E., Abdelsalam, M. (2018). 'Intensity Modulated Radiation Therapy versus Supportive Care in Malignant Pleural Mesothelioma: A Pilot Study for Treatment Outcomes and Cost-Effective Expectations', Research in Oncology, 14(1), pp. 6-11. doi: 10.21608/resoncol.2018.2409.1042
Ellithy, M., Ashoush, N., El Shahat, K., Ahmed, E., Abdelsalam, M. Intensity Modulated Radiation Therapy versus Supportive Care in Malignant Pleural Mesothelioma: A Pilot Study for Treatment Outcomes and Cost-Effective Expectations. Research in Oncology, 2018; 14(1): 6-11. doi: 10.21608/resoncol.2018.2409.1042

Intensity Modulated Radiation Therapy versus Supportive Care in Malignant Pleural Mesothelioma: A Pilot Study for Treatment Outcomes and Cost-Effective Expectations

Article 3, Volume 14, Issue 1, June 2018, Page 6-11  XML PDF (375.05 K)
Document Type: Original Article
DOI: 10.21608/resoncol.2018.2409.1042
View on SCiNiTO View on SCiNiTO
Authors
Mahmoud Ellithy email 1; Nermeen Ashoush2; Khalid El Shahat3; Emad Ahmed4; Mahmoud Abdelsalam5
1Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
2Clinical Pharmacy Department, Faculty of Pharmacy, British University in Cairo, Cairo, Egypt
3Clinical Oncology Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
4Radiation physics Department, International Medical Center, Medical branch of Egyptian Armed Forces, Cairo, Egypt
5Hematology Oncology Department, International Medical Center, Medical branch of Egyptian Armed Forces, Cairo, Egypt.
Abstract
Background: Malignant pleural mesothelioma (MPM) is an aggressive tumor. The outcome of treatment of Egyptian
MPM patients is not satisfactory and its cost-effectiveness is questionable.
Aim: The study aimed to test the treatment outcome and cost-effectiveness of intensity modulated radiation therapy
(IMRT) in unresectable MPM patients who exhausted the standard treatment modalities.
Methods: Twenty-four eligible patients were randomized (1:1) to either a control group receiving best supportive care
(BSC) or an intervention group receiving IMRT to the tumor volume. Quality of life (QoL) was assessed by the European
Organization for Research and Treatment of Cancer QoL questionnaires QLQ-C30 and QLQ-LC13 (lung cancer module).
Tumor progression was monitored by serial computerized tomography scans. Assessment was done at enrollment and after
4 months. Incremental cost-effectiveness ratio (ICER) was calculated for BSC vs. IMRT. The output data of the ICER
were total costs, overall survival (OS), progression-free survival (PFS) for each treatment modality.
Results: The median OS did not differ significantly between IMRT and BSC (13 versus 11 months, respectively; p=0.117)
while the median PFS was significantly longer with IMRT (6 versus 4 months, respectively; p=0.009). The IMRT group < br />demonstrated a significant deterioration in their final QoL scores compared to baseline. IMRT had an incremental cost of
5912 USD per patient with an incremental effectiveness of 4 months of PFS, providing an ICER of 6.260.
Conclusion: Although it may be associated with longer PFS, IMRT in MPM with intact lung is likely detrimental and not
cost-effective.
Keywords
Malignant Pleural Mesothelioma; intensity modulated radiation therapy; quality of life; Cost-effectiveness; Egypt
Statistics
Article View: 690
PDF Download: 728
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.